NCT01913964View on ClinicalTrials.gov

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1997

Primary Completion Date

October 31, 1997

Study Completion Date

October 31, 1997

Conditions
Work Productivity and Activity Impairment in Workers With Chronic C HepatitisFatigue in Workers With Chronic C HepatitisFatigue
Interventions
DRUG

Acetylcarnitine

DRUG

Placebo

(sugar pill)

All Listed Sponsors
lead

University of Catania

OTHER

NCT01913964 - Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin | Biotech Hunter | Biotech Hunter